CC
CRNX icon

Commodore Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Commodore Capital’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500,000
Closed -$14.9M – 33
2023
Q3 		$14.9M Buy
+500,000
New +$14.9M 1.74% 20